Lumedica published two papers in Biomedical Optics Express #BOE: one on a multimodal retinal imaging device combining high performance/low-cost OCT with light scattering using a/LCI, and another on an automated pipeline to segment cardiac organoids using OCT.
Published
Signal category
Research & Knowledge
Quote
“First was on our multimodal retinal imaging device combining high performance/low-cost OCT with light scattering using a/LCI”
— Adam Wax|Lumedica team
Company
Lumedica
We make low-cost, high-performance Optical Coherence Tomography (OCT) imaging technologies.
- Industry
- Medical Device
- Location
- Durham, US
- Company size
- 9 employees
We are believers in — and builders of — affordable, accessible healthcare technologies. Our aim is to disrupt the economics of healthcare by creating low-cost, high-tech diagnostic instruments that are accurate and easy to use. Lumedica is currently developing and delivering its first fully-patented technology to market: affordable OCT (Optical Coherence Tomography). The Lumedica team has a proven track record in scientific innovation, product development, and private and public fundraising. Lumedica is currently funded by grants from the NIH and the State of North Carolina.
Founded 2014